REG - Anpario PLC - Full year trading statement

AnparioAnnouncement

10/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250110:nRSJ8294Sa&default-theme=true

RNS Number : 8294S  Anpario PLC  10 January 2025

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR
MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE
MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

 

Anpario plc
("Anpario", the "Group" or the "Company")

 

Full year trading statement

 

Anpario plc (AIM:ANP), the independent manufacturer of natural sustainable
animal feed additives for health, nutrition and biosecurity, provides the
following trading update for the year ended 31 December 2024 ("FY 2024"). The
figures set out in this announcement remain subject to audit.

 

Trading update

The Group, including three months of trading for Bio-Vet Inc., delivered a
stronger than expected operating performance in the second half of 2024.
Year-end sales were higher than anticipated, and the Group now expects revenue
for the 12 months ended 31 December 2024 to be approximately £37.5m* (31
December 2023: £31.0m). This strong performance in revenue combined with the
Group's high operational gearing and favourable year-end foreign exchange
movements, will result in adjusted EBITDA being ahead of current market
expectations*.

 

Bio-Vet Inc. had a strong final quarter due to heightened demand for its
products, which support the health of dairy cows affected by avian influenza,
and our Middle East and Africa segment delivered an outstanding sales
performance.

 

Financial position

Our financial position remains strong, with year-end cash balances of £10.5m*
(31 December 2023: £10.6m), after accounting for the acquisition of Bio-Vet
Inc. and associated land and buildings for an initial cash consideration of
US$6.3m, on a debt-free basis, which completed in September 2024.

 

Our strong balance sheet enables the Group to invest in innovative natural
product solutions, expand our global reach and explore earnings enhancing and
complementary acquisitions to continue the profitable development of the
Group. We remain confident in our ability to capitalise on growth
opportunities, delivering long-term benefits to all stakeholders.

 

FY2024 Results

The Group expects to publish its FY 2024 final results on or around 26 March
2025.

 

 

 

*Analyst consensus for FY 2024 immediately prior to this announcement was
Revenue of £35.25m, EBITDA of £5.7m and net cash of £7.2m.

 

Enquiries

 

 Anpario plc
 Richard Edwards, Chief Executive Officer  +44(0)7776 417 129
 Marc Wilson, Group Finance Director       +44(0)1909 537 380

 Shore Capital
 (Nominated Adviser and Broker)            +44 (0) 20 7408 4090
 Stephane Auton                            Corporate Advisory
 David Coaten
 Tom Knibbs
 Henry Willcocks                           Corporate Broking

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTUPUUUGUPAPWB